维罗纳制药(VRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRNA 维罗纳制药

休市中 05-02 16:00:00 EDT

72.73

+0.47

+0.65%

盘后72.73

+0.000.00%

19:54 EDT

最高73.93	最低71.19	成交量144.91万
今开72.74	昨收72.26	日振幅3.80%
总市值61.92亿	流通市值45.02亿	总股本8,513万
成交额1.05亿	换手率2.34%	流通股本6,189万
市净率27.32	ROE-72.61%	每股收益-2.02
52周最高74.18	52周最低11.39	市盈率-36.05
股息0.00	股息收益率0.00	ROA-20.64%

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRNA","market":"US","secType":"STK","nameCN":"维罗纳制药","latestPrice":72.73,"timestamp":1746216000000,"preClose":72.26,"halted":0,"volume":1449076,"hourTrading":{"tag":"盘后","latestPrice":72.73,"preClose":72.73,"latestTime":"19:54 EDT","volume":11029,"amount":802136.35,"timestamp":1746230087146},"delay":0,"floatShares":61894000,"shares":85132002,"eps":-2.017734,"marketStatus":"休市中","change":0.47,"latestTime":"05-02 16:00:00 EDT","open":72.74,"high":73.93,"low":71.1862,"amount":105464867.06852001,"amplitude":0.037971,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.017734,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":1,"adrRate":8,"listingDate":1493265600000,"exchange":"NASDAQ","adjPreClose":72.26,"preHourTrading":{"tag":"盘前","latestPrice":74.9,"preClose":72.26,"latestTime":"09:25 EDT","volume":720,"amount":52111.2384,"timestamp":1746192300050},"postHourTrading":{"tag":"盘后","latestPrice":72.73,"preClose":72.73,"latestTime":"19:54 EDT","volume":11029,"amount":802136.35,"timestamp":1746230087146},"volumeRatio":0.6173396281795042,"impliedVol":0.6485,"impliedVolPercentile":0.38},"requestUrl":"/m/hq/s/VRNA","defaultTab":"news","newsList":[{"id":"2532355159","title":"维罗纳制药2025财年第一财季实现净利润-16.38百万美元，同比增加36.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532355159","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532355159?lang=zh_cn&edition=full","pubTime":"2025-05-04 00:00","pubTimestamp":1746288047,"startTime":"0","endTime":"0","summary":"5月4日，维罗纳制药公布财报，公告显示公司2025财年第一财季净利润为-16.38百万美元，同比增加36.46%；其中营业收入为76.55百万美元，每股基本收益为-0.19美元。从资产负债表来看，维罗纳制药总负债2.99亿美元，其中短期债务1.08百万美元，资产负债比为1.76，流动比率为0.09。机构评级：截至2025年5月4日，当前有11家机构对维罗纳制药目标价做出预测，其中目标均价为92.36美元，其中最低目标价为75.00美元，最高目标价为107.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250504000101a6d2261f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250504000101a6d2261f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA"],"gpt_icon":0},{"id":"2532006807","title":"富国银行：维持Verona Pharma评级，由增持调整至增持评级, 目标价由93.00美元调整至107.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2532006807","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532006807?lang=zh_cn&edition=full","pubTime":"2025-05-01 00:15","pubTimestamp":1746029756,"startTime":"0","endTime":"0","summary":"富国银行：维持Verona Pharma(VRNA.US)评级，由增持调整至增持评级, 目标价由93.00美元调整至107.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050100180694e927a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050100180694e927a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA"],"gpt_icon":0},{"id":"2530618769","title":"维罗纳制药盘中异动 快速上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530618769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530618769?lang=zh_cn&edition=full","pubTime":"2025-04-25 02:35","pubTimestamp":1745519717,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日02时35分，维罗纳制药股票出现波动，股价急速拉升5.13%。截至发稿，该股报66.56美元/股，成交量84.0272万股，换手率0.99%，振幅6.07%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为0.49%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042502351794e1603e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042502351794e1603e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2529398736","title":"维罗纳制药盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529398736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529398736?lang=zh_cn&edition=full","pubTime":"2025-04-23 22:33","pubTimestamp":1745418804,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日22时33分，维罗纳制药股票出现波动，股价快速拉升5.01%。截至发稿，该股报65.12美元/股，成交量23.5337万股，换手率0.28%，振幅3.74%。机构评级方面，在所有10家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为1.55%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423223325aa2c790f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423223325aa2c790f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2526561380","title":"维罗纳制药盘中异动 股价大涨5.01%报56.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526561380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526561380?lang=zh_cn&edition=full","pubTime":"2025-04-12 00:36","pubTimestamp":1744389370,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日00时36分，维罗纳制药股票出现波动，股价大幅拉升5.01%。截至发稿，该股报56.63美元/股，成交量35.5977万股，换手率0.42%，振幅5.47%。最近的财报数据显示，该股实现营业收入42.30百万美元，净利润-1.73亿美元，每股收益-2.13美元，毛利38.66百万美元，市盈率-26.20倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为1.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412003610aa2c6cf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412003610aa2c6cf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2518270202","title":"维罗纳制药盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518270202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518270202?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615203,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，维罗纳制药股票出现异动，股价急速下挫5.10%。截至发稿，该股报61.35美元/股，成交量18.6847万股，换手率0.22%，振幅5.01%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为0.04%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022000398a2a46c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022000398a2a46c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2517616769","title":"维罗纳制药2024财年实现净利润-1.73亿美元，同比减少216.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517616769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517616769?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:00","pubTimestamp":1741276856,"startTime":"0","endTime":"0","summary":"3月7日，维罗纳制药公布财报，公告显示公司2024财年净利润为-1.73亿美元，同比减少216.97%；其中营业收入为42.30百万美元，每股基本收益为-2.13美元。从资产负债表来看，维罗纳制药总负债2.70亿美元，其中短期债务1.12百万美元，资产负债比为1.76，流动比率为0.11。机构评级：截至2025年3月7日，当前有9家机构对维罗纳制药目标价做出预测，其中目标均价为80.33美元，其中最低目标价为72.00美元，最高目标价为93.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000116abeb8d03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000116abeb8d03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA"],"gpt_icon":0},{"id":"2516663450","title":"维罗纳制药盘中异动 下午盘急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663450?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:28","pubTimestamp":1741033720,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时28分，维罗纳制药股票出现波动，股价急速下跌5.04%。截至发稿，该股报66.12美元/股，成交量93.7822万股，换手率1.10%，振幅5.97%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体跌幅为0.03%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042841a25da2e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042841a25da2e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2516342377","title":"富国银行：维持Verona Pharma(VRNA.US)评级，由增持调整至增持评级, 目标价由74.00美元调整至93.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516342377","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516342377?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:41","pubTimestamp":1740764502,"startTime":"0","endTime":"0","summary":"富国银行：维持Verona Pharma(VRNA.US)评级，由增持调整至增持评级, 目标价由74.00美元调整至93.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01014148470009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VRNA"],"gpt_icon":0},{"id":"2514385408","title":"维罗纳制药盘中异动 早盘大幅上涨5.50%报67.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385408?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:31","pubTimestamp":1740666693,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，维罗纳制药股票出现波动，股价大幅拉升5.50%。截至发稿，该股报67.02美元/股，成交量11.6995万股，换手率0.14%，振幅1.68%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为0.06%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223134a25679cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223134a25679cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"1153024152","title":"威罗纳制药2024年第四季度GAAP每股亏损$(0.40)，不及预期$(0.29)，销售额$36.64M超预期$33.05M","url":"https://stock-news.laohu8.com/highlight/detail?id=1153024152","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153024152?lang=zh_cn&edition=full","pubTime":"2025-02-27 19:27","pubTimestamp":1740655621,"startTime":"0","endTime":"0","summary":"威罗纳制药报告季度每股亏损为$，未达到分析师普遍预期的$，低于预期37.93%。与去年同期的每股亏损$相比，下降了122.22%。公司报告季度销售额为$36.64百万，超过分析师预期的$33.05百万，增长10.86%。以上内容来自Benzinga Earnings专栏，原文如下：Verona Pharma  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 37.93 percent. This is a 122.22 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $36.64 million which beat the analyst consensus estimate of $33.05 million by 10.86 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"威罗纳制药2024年第四季度GAAP每股亏损$(0.40)，不及预期$(0.29)，销售额$36.64M超预期$33.05M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRNA"],"gpt_icon":1},{"id":"2514851351","title":"维罗纳制药盘中异动 快速上涨5.27%报65.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851351?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:47","pubTimestamp":1740581223,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时47分，维罗纳制药股票出现波动，股价急速上涨5.27%。截至发稿，该股报65.68美元/股，成交量17.1494万股，换手率0.21%，振幅5.55%。最近的财报数据显示，该股实现营业收入5.68百万美元，净利润-43.40百万美元，每股收益-0.57美元，毛利4.86百万美元，市盈率-32.84倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体跌幅为0.30%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262247039631526f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262247039631526f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2514041843","title":"维罗纳制药盘中异动 快速下挫5.06%报62.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514041843?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:52","pubTimestamp":1740516764,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时52分，维罗纳制药股票出现波动，股价快速下跌5.06%。截至发稿，该股报62.28美元/股，成交量166.843万股，换手率2.04%，振幅4.88%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为0.12%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045245a253dddc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045245a253dddc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2513529212","title":"维罗纳制药盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513529212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513529212?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:53","pubTimestamp":1740153226,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时53分，维罗纳制药股票出现波动，股价急速拉升5.12%。截至发稿，该股报67.48美元/股，成交量58.9219万股，换手率0.72%，振幅4.81%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为0.02%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221235346988df087&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221235346988df087&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2511661358","title":"维罗纳制药盘中异动 股价大涨5.06%报64.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511661358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511661358?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:30","pubTimestamp":1739554207,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时30分，维罗纳制药股票出现异动，股价急速拉升5.06%。截至发稿，该股报64.79美元/股，成交量101.198万股，换手率1.24%，振幅5.49%。最近的财报数据显示，该股实现营业收入5.68百万美元，净利润-43.40百万美元，每股收益-0.57美元，毛利4.86百万美元，市盈率-32.34倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体跌幅为0.63%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013008abcf2caa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215013008abcf2caa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2510377141","title":"加拿大投资银行集团：维持Verona Pharma(VRNA.US)评级，由买入调整至买入评级, 目标价由44.00美元调整至72.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510377141","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510377141?lang=zh_cn&edition=full","pubTime":"2025-02-12 22:01","pubTimestamp":1739368906,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Verona Pharma(VRNA.US)评级，由买入调整至买入评级, 目标价由44.00美元调整至72.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12220148121739.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VRNA"],"gpt_icon":0},{"id":"2508128024","title":"维罗纳制药盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508128024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508128024?lang=zh_cn&edition=full","pubTime":"2025-02-04 00:36","pubTimestamp":1738600565,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日00时36分，维罗纳制药股票出现异动，股价急速拉升5.25%。截至发稿，该股报60.31美元/股，成交量101.761万股，换手率1.24%，振幅8.10%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体跌幅为0.60%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020400360596170ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020400360596170ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRNA","BK4007"],"gpt_icon":0},{"id":"2507662714","title":"维罗纳制药盘中异动 急速拉升5.16%报57.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507662714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507662714?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:14","pubTimestamp":1738250095,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时14分，维罗纳制药股票出现异动，股价大幅拉升5.16%。截至发稿，该股报57.66美元/股，成交量35.2636万股，换手率0.43%，振幅5.33%。最近的财报数据显示，该股实现营业收入5.68百万美元，净利润-43.40百万美元，每股收益-0.57美元，毛利4.86百万美元，市盈率-28.73倍。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体跌幅为0.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231456a2345cf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130231456a2345cf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"2504195622","title":"维罗纳制药盘中异动 早盘大幅跳水5.07%报50.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504195622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504195622?lang=zh_cn&edition=full","pubTime":"2025-01-18 00:13","pubTimestamp":1737130380,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日00时13分，维罗纳制药股票出现异动，股价快速下跌5.07%。截至发稿，该股报50.92美元/股，成交量45.5716万股，换手率0.56%，振幅5.03%。机构评级方面，在所有9家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。维罗纳制药股票所在的生物技术行业中，整体涨幅为0.65%。维罗纳制药公司简介：Verona Pharma PLC是一家临床阶段的生物制药公司，专注于开发和商业化治疗未满足医疗需求的呼吸系统疾病的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118001300a225d378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118001300a225d378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRNA"],"gpt_icon":0},{"id":"1199093944","title":"异动解读 | 维罗纳制药(VRNA)盘中大涨5.03% 呼吸系统药物开发前景广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=1199093944","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199093944?lang=zh_cn&edition=full","pubTime":"2025-01-15 00:35","pubTimestamp":1736872528,"startTime":"0","endTime":"0","summary":"维罗纳制药今日盘中上涨5.03%,引发市场高度关注。这一上涨可能与投资者看好公司在呼吸系统疾病领域的药物开发前景有关。作为一家临床阶段的生物制药公司,维罗纳制药目前主要专注于开发可治疗慢性阻塞性肺疾病、囊性纤维化等呼吸系统疾病的候选药物Ensifentrine。随着人口老龄化加剧,呼吸系统疾病患者人数不断增加,对相关治疗药物的需求日益增长。如果后续临床试验取得成功,可能会进一步推升其股价表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 维罗纳制药(VRNA)盘中大涨5.03% 呼吸系统药物开发前景广阔","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VRNA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.veronapharma.com","stockEarnings":[{"period":"1week","weight":0.1111},{"period":"1month","weight":0.2063},{"period":"3month","weight":0.2693},{"period":"6month","weight":1.0792},{"period":"1year","weight":3.6178},{"period":"ytd","weight":0.5661}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"维罗纳制药公司根据英格兰及威尔士的法律以Isis Resources plc为名于2005年2月24日注册成立。2006年9月，该公司收购了在加拿大注册成立的私人公司Rhinopharma Limited，并更名为维罗纳制药公司。该公司是一家临床阶段的生物制药公司，专注于开发和商业化创新治疗方法，用于治疗具有显著未满足的医疗需求的呼吸系统疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.042371},{"month":2,"riseRate":0.5,"avgChangeRate":0.048229},{"month":3,"riseRate":0.25,"avgChangeRate":-0.023426},{"month":4,"riseRate":0.375,"avgChangeRate":-0.038912},{"month":5,"riseRate":0.555556,"avgChangeRate":-0.0224},{"month":6,"riseRate":0.25,"avgChangeRate":-0.037719},{"month":7,"riseRate":0.625,"avgChangeRate":0.1404},{"month":8,"riseRate":0.5,"avgChangeRate":0.11834},{"month":9,"riseRate":0.375,"avgChangeRate":0.007343},{"month":10,"riseRate":0.25,"avgChangeRate":-0.009258},{"month":11,"riseRate":0.375,"avgChangeRate":0.006476},{"month":12,"riseRate":0.75,"avgChangeRate":0.295436}],"exchange":"NASDAQ","name":"维罗纳制药","nameEN":"Verona Pharma plc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"维罗纳制药(VRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供维罗纳制药(VRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"维罗纳制药,VRNA,维罗纳制药股票,维罗纳制药股票老虎,维罗纳制药股票老虎国际,维罗纳制药行情,维罗纳制药股票行情,维罗纳制药股价,维罗纳制药股市,维罗纳制药股票价格,维罗纳制药股票交易,维罗纳制药股票购买,维罗纳制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"维罗纳制药(VRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供维罗纳制药(VRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}